AnalCancer News

Share

AnalCancer News


Study Confirms Role of Ovarian Suppression and Aromasin for Younger Women With Hormone-sensitive Breast Cancer (December 19, 2014)

CancerConnect News: Ovarian suppression combined with the anti-estrogen drug Aromasin® (exemestane) appears to greatly reduce the risk of breast cancer recurrence in younger women according to the results... Continue Reading

Long term Follow up Confirms Success of MGH-developed Laser Treatment for Vocal-cord Cancer (December 19, 2014)

More than three years after pulsed-KTP laser treatment, 96 percent of patients with early vocal-cord tumors are cancer-free. The first long-term study of a pioneering endoscopic laser treatment for early... Continue Reading

Breast Cancer Patients Are Now Living Longer without Relapse (December 18, 2014)

CancerConnect News: Survival without relapse for patients with early-stage breast cancer has improved significantly over the past 30 years, particularly among women with HER2-positive disease. These findings... Continue Reading

PD-1 Immunotherapy Shows Promise in Hodgkin’s Lymphoma (December 18, 2014)

CancerConnect News:The cancer immunotherapy strategy known as programmed cell death 1 (PD-1) has generated great excitement for its ability to help the immune system recognize and attack cancer. Now according... Continue Reading

Some Older Women with Early-Stage Breast Cancer May Be Receiving Radiation That Is Unlikely to Add Benefit (December 17, 2014)

CancerConnect News Up to two-thirds of older women with early-stage breast cancer may be receiving radiation therapy that may not provide additional benefit. These findings were recently released online... Continue Reading

HIV-Positive Patients with Lymphoma Should No Longer be Excluded From Receiving Blood Stem Cell Transplants as Treatment (December 17, 2014)

CancerConnect News: HIV-positive patients with lymphoma were previously excluded from receiving autologous blood stem cell transplants as treatment, because of concern that these patients’ compromised... Continue Reading

IBIS-I Trial Confirms Greater Than Fifteen Year Benefit of Tamoxifen to Reduce Risk of Breast Cancer in High-Risk Women (December 16, 2014)

CancerConnect News: Long term results of the International Breast Cancer Intervention Study-I (IBIS-I) were presented at the 2014 San Antonio Breast Cancer Symposium, confirming that tamoxifen significantly... Continue Reading

Jakafi® Helps Maintain Blood Cells Levels in Polycythemia Vera (December 16, 2014)

CancerConnect News: A new drug called Jakafi® (ruxolitinib) appears to help patients with polycythemia vera (PV) maintain hematocrit control more effectively than best available therapy. These findings... Continue Reading

Neratinib Continues to Show Activity in HER2-Positive Breast Cancer (December 15, 2014)

CancerConnect News: Interim results from an ongoing Phase II clinical trial of neratinib were presented at the 2014 San Antonio Breast Cancer Symposium (SABCS). Neratinib is an investigational, oral medication... Continue Reading

Switching from Best Available Therapy to Jakafi® Improves Outcomes in Polycythemia Vera (December 15, 2014)

CancerConnect News: Patients with polycythemia vera (PV) who begin treatment with best available therapy and then switch to treatment with Jakafi® (ruxolitinib) experience improved outcomes. These findings... Continue Reading

More AnalCancer News

Latest AnalCancer News By Stage

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS